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ABSTRACT 
Gastro retardation is attractive approach to enhance bioavailability of narrow absorption window drugs. Drug retardation in stomach 
is more beneficial for certain gastro intestinal disorders like gastro esophageal reflex disease, ulcer and other gastro intestinal 
conditions. Gastric site retardation is one of the challenging technique, however various techniques are applied to keep the drug and 
achieve the enhancement of bioavailability. To achieve gastro retentive commonly two approaches are considered, they are floating 
drug delivery system and non-floating gastro retentive drug delivery system. The floating drug made-up by low density polymers, 
this approach was not fit many of the drug molecule and floating drug has some limitations like sufficient level fluids in stomach and 
not to be dosed just before going to bed. In this review describe the various high density (sinking) system (non-floating) drug 
delivery systems like super porous hydrogels, expanding system, bio/mucoadhesives system, and magnetic system and mechanism, 
desirable drug characters, advantages and disadvantages.  
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INTRODUCTION 
Gastro retentive drug delivery system improves drug 
efficiency, reduce frequency of administration, enhance 
bioavailability and better patient’s compliance. Several 
gastro retentive drug delivery approaches being designed 
and developed, sinking (high density) systems (that is 
retained in the bottom of the stomach), floating (low 
density) systems that causes buoyancy in gastric fluid, 
mucoadhesive systems that causes bio adhesion to 
stomach mucosa, extendible or swellable systems which 
exact delivery of drug dosage in stomach.
1 
Floating systems or hydro dynamically controlled 
systems that have float the tablet over the stomach 
contents for a prolonged period of time.
2
 The drug is 
released slowly at the desired rate from the system, after 
the drug release the residual system is emptied from the 
stomach. These results in an increased gastro retardation 
time (GRT) for the system buoyancy a minimal gastric 
content needed. Sinking high density approach involves 
formulation of dosage forms with the density that must 
exceed density of normal stomach content
1
.
 
Mucoadhesive dosage forms designed prolonged 
retention at the gastric site, providing a controlled rate of 
drug release for improved therapeutic 
outcome. Extendible dosage (swellable) form in the 
stomach will withstand gastric transit if it bigger than 
pyloric sphincter
1
. The current review brief about 
various non-floating gastroretentive approaches of drug 
delivery systems. The successful development of gastric 
retardation drug delivery systems requires an 
understanding of anatomy and physiology of gastro 
intestinal tract (GIT) and physiochemical character of 
drug. 
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A glance of gastro intestinal tract 
The stomach is divided into three regions, fundus, body, 
and antrum (pylorus). The proximal part made of fundus 
and body acts as a reservoir for undigested material, 
whereas the antrum is the main site for mixing motions 
and act as a pump for gastric emptying by propelling 
actions. Gastric emptying occurs during fasting as well 
as fed states. The pattern of motility is differ in the two 
states. During the fasting state series of electrical events 
take place, which cycle both through stomach and 
intestine every 2 to 3 hours, this is called interdigestive 
myloelectric cycle or migrating myloelectric cycle 
(MMC), which is further divided into following 4 
phase.
3,4
  
1. Phase I (basal phase) lasts from 30 to 60 minutes 
with rare contractions.
5
  
2. Phase II (preburst phase) lasts for 20 to 40 minutes 
with intermittent action potential and contractions. As 
the phase progresses the intensity and frequency also 
increases gradually.
6
  
3. Phase III (burst phase) lasts for 10 to 20 minutes.
7
 It 
includes intense and regular contractions for short 
period. It is due to this wave that all the undigested 
material is swept out of the stomach down to the small 
intestine. It is also known as the housekeeper wave.  
4. Phase IV lasts for 0-5 minutes and occurs between 
phases III and I of 2 consecutive cycles.
8
  
After consumption of meal, the pattern of contractions 
changes from fasted to feed state. This is known as 
digestive motility pattern and comprises continuous 
contractions as in phase II of fasted state. These 
contractions result in reducing the size of food particles 
(to less than 1 mm), which are propelled toward the 
pylorus in a suspension form. During the fed state onset 
of migrating myloelectric cycle is delayed resulting in 
slowdown of gastric emptying rate. 
6,9,10 
 
Gastro retentive drug delivery system desirable 
characters 
1. Drugs that act locally in the stomach e.g., Antacids 
and Misoprostol
1,11
  
2. Drugs that are primarily absorbed in the stomach. e.g. 
Calcium supplements, Chlordiazepoxide and 
Cinnarazine.  
3. Drugs those are poorly soluble at an alkaline pH.  
4. Drugs that have a narrow window of absorption. e.g., 
Riboflavin and Levodopa.  
5. If the drugs disturb normal colonic microbes. 
6. Drugs that is unstable in the intestinal or colonic 
environment. e.g. Ranitidine and Metronidazole.  
7. Drugs with variable bioavailability. E.g. Sotalol HCl 
Advantages of Gastro retentive drug delivery 
system
6,10 
1. Enhanced drug absorption. 
2. Controlled drug delivery. 
3. Delivery of drugs for local action in the stomach. 
4. Minimizing the mucosal irritation due to slow and 
controlled rate. 
5. Highly suitable for the treatment of gastrointestinal 
disorders such as gastro-esophageal reflux. 
6. Simple and conventional equipment is enough for 
formulate. 
7. Site-specific drug delivery. 
Disadvantages of gastroretentive drug delivery 
systems
6,11 
1. Unsuitable for drugs with limited acid solubility.  
2. Unsuitable for drugs that are unstable in acidic 
environment. 
3. Drugs that irritates or causes gastric lesions on slow 
release. E.g. Aspirin & NSAID’s 
4. Unsuitable drugs that absorb selectively in colon. 
5. Floating drug delivery systems require high fluid 
level in stomach to float and work effectively.
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High density systems 
Super porous hydrogels 
Expanding systems 
Swelling systems 
Unfoldable  systems 
Bio/mucoadhesive  
system 
Magnetic systems 
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Sinking (High Density) Systems 
These systems, which have a density of 3g/cm
3
 are 
retained in the stomach and capable of withstanding its 
peristaltic movements. The only drawback with these 
systems is that, it is technically difficult to manufacture 
them with a large amount of drug (>50%) and achieve 
required density of 2.4‐2.8g/cm3. Diluents such as 
barium sulphate (density= 4.9), zinc oxide, titanium 
oxide, and iron powder must be used to manufacture 
such high‐density formulation.5,6 
Super porous hydrogel systems 
The approach to improve gastric retention time (GRT) 
by super porous hydrogels of average pore size >100 
micro meter, swell to equilibrium size within a minute 
due to rapid water uptake by capillary and  wetting 
through numerous interconnected open pores.  
They swell to a large size (swelling ratio: 100 or more) 
and are intended to have sufficient mechanical strength 
to withstand pressure by gastric contraction. This is 
advised by co-formulation of hydrophilic particulate 
material.
1,6
 This is achieved by co-formulation of a 
hydrophilic particulate material, and Ac-Di-Sol 
(crosscarmellose). 
Swelling system (Expandable systems) 
The swelling is usually results from osmotic absorption 
of water. The dosage form in the stomach will withstand 
gastric transit if it bigger than pyloric sphincter. These 
system may be reffered as a ‘plug type system’ the 
device gradually decreases in volume and rigidity. The 
final small form of dosage enabling evacuation 
following drug release from the system.
4,11 
Unfoldable and swellable systems  
Unfolding systems are systems which are actually of 
larger size but they are folded to decrease size and kept 
in capsules. In stomach these systems comes out of 
capsules and unfolds to larger size.  The important 
factor for unfolding system is shape memory. They 
should have sufficient shape memory such that they 
retain their unfolded (expanded) shape in stomach 
against gastric motility and not get folded again and 
escape out till the desired time interval.  
Unfoldable systems are available in various shapes. 
Caldwell et al, proposed different geometric forms like 
tetrahedron, ring or planar membrane, 4-lobed, disc and 
4-limbed cross form of bioerodible polymer compressed 
within a capsule. Expandable systems have some 
drawbacks like easily hydrolysable, biodegradable 
polymers relatively short-lived mechanical shape, 
difficult to industrialize and not cost effective.
4, 12, 14
 
Muco / Bio-adhesive systems  
Muco/Bioadhesive drug delivery systems (BDDS) are 
used to make delivery of drug in lumen of GIT and 
facilitate drug absorption in a site specific site. This 
approach involves the use of bioadhesive polymers, 
which can adhere to the epithelial surface in the 
stomach. The basis of mucoadhesion is that a dosage 
form can stick to the mucosal surface by different 
mechanisms. The drawback of Gastric mucoadhesion 
does not tend to be strong enough to impart to dosage 
forms the ability to resist the strong propulsion forces of 
the stomach wall. The commonly used excipients are 
polycarbophil, carbopol, lectins, chitosan and gliadin, 
etc.
1, 4, 12
. As the mucoadhesivity improves the retention 
time of the formulation at the site of absorption in GIT, 
so it helps a sustained release effect for a longer period
13
 
Magnetic Systems 
Based upon the principle that dosage form contains a 
small internal magnet, and a magnet placed on the 
abdomen over the position of stomach can enhance the 
gastro retardation time. Although magnetic system 
seems to work, the external magnet must be positioned 
with a degree of precision that might compromise 
patient compliance.
12
 
DISCUSSION 
Novelty in gastro retardation is attractive and most 
beneficial technique for narrow absorption window 
drugs. Retarding the drug in gastric site is real 
challenging work, and to face lot of biological 
constrains, formulation and patients side considerations. 
These techniques are very much fit for ulcer curative 
antibiotic therapies, those drugs are used in high 
concentration in conditions like helicobacter pylori 
infection eradication. Prolonged drug release can 
produce better bioavailability and good patient 
compliance. However the complexity of 
pharmacokinetic and pharmacodynamics parameters 
invivo studies are required to establishment of specific 
drug dosage. All types of gastroretardation techniques 
are have its own merits and demerits. Nowadays lot of 
research in this field has provided variety of techniques 
to adopt and make designer drug in gastro retardation.  
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